The Clorox Company $CLX Stock Holdings Reduced by Handelsbanken Fonder AB

Handelsbanken Fonder AB lowered its position in The Clorox Company (NYSE:CLX) by 54.6% during the fourth quarter, according to its most recent Form 13F filing with the Securities and Exchange Commission (SEC). The institutional investor owned 39,400 shares of the company’s stock after selling 47,394 shares during the quarter. Handelsbanken Fonder AB’s holdings in Clorox were worth $3,973,000 at the end of the most recent quarter.

A number of other institutional investors and hedge funds have also recently bought and sold shares of the company. State Street Corp grew its stake in Clorox by 3.5% in the third quarter. State Street Corp now owns 8,434,277 shares of the company’s stock valued at $1,039,946,000 after purchasing an additional 282,794 shares in the last quarter. Invesco Ltd. grew its stake in Clorox by 23.1% in the third quarter. Invesco Ltd. now owns 3,995,590 shares of the company’s stock valued at $492,656,000 after purchasing an additional 750,415 shares in the last quarter. Van ECK Associates Corp grew its stake in Clorox by 93.9% in the third quarter. Van ECK Associates Corp now owns 2,709,972 shares of the company’s stock valued at $334,139,000 after purchasing an additional 1,312,471 shares in the last quarter. Two Sigma Investments LP grew its stake in Clorox by 33.8% in the third quarter. Two Sigma Investments LP now owns 1,740,175 shares of the company’s stock valued at $214,564,000 after purchasing an additional 439,797 shares in the last quarter. Finally, Northern Trust Corp grew its stake in Clorox by 4.8% in the third quarter. Northern Trust Corp now owns 1,539,006 shares of the company’s stock valued at $189,759,000 after purchasing an additional 70,783 shares in the last quarter. Hedge funds and other institutional investors own 78.53% of the company’s stock.

Insider Activity

In other Clorox news, Director Pierre R. Breber acquired 5,000 shares of the business’s stock in a transaction that occurred on Tuesday, May 5th. The stock was acquired at an average price of $85.82 per share, with a total value of $429,100.00. Following the transaction, the director owned 18,000 shares of the company’s stock, valued at approximately $1,544,760. This trade represents a 38.46% increase in their ownership of the stock. The acquisition was disclosed in a filing with the Securities & Exchange Commission, which is accessible through this link. Company insiders own 0.63% of the company’s stock.

Clorox Stock Performance

CLX opened at $94.97 on Friday. The company has a market cap of $11.48 billion, a PE ratio of 15.42, a price-to-earnings-growth ratio of 0.49 and a beta of 0.59. The stock has a 50-day moving average of $99.99 and a 200-day moving average of $106.29. The Clorox Company has a 52-week low of $84.70 and a 52-week high of $132.03. The company has a debt-to-equity ratio of 27.03, a quick ratio of 0.65 and a current ratio of 0.84.

Clorox (NYSE:CLX) last released its quarterly earnings results on Thursday, April 30th. The company reported $1.64 earnings per share (EPS) for the quarter, topping the consensus estimate of $1.55 by $0.09. The company had revenue of $1.67 billion during the quarter, compared to the consensus estimate of $1.67 billion. Clorox had a return on equity of 443.64% and a net margin of 11.18%.The firm’s revenue was up .1% on a year-over-year basis. During the same quarter in the prior year, the company posted $1.45 EPS. Clorox has set its FY 2026 guidance at 5.450-5.650 EPS. As a group, equities research analysts forecast that The Clorox Company will post 5.61 earnings per share for the current fiscal year.

Clorox Dividend Announcement

The business also recently declared a quarterly dividend, which was paid on Friday, May 8th. Stockholders of record on Wednesday, April 22nd were paid a dividend of $1.24 per share. This represents a $4.96 annualized dividend and a dividend yield of 5.2%. The ex-dividend date was Wednesday, April 22nd. Clorox’s dividend payout ratio is 80.52%.

Wall Street Analysts Forecast Growth

CLX has been the topic of a number of recent research reports. Royal Bank Of Canada lowered their target price on Clorox from $132.00 to $127.00 and set a “sector perform” rating on the stock in a research note on Thursday, April 9th. Jefferies Financial Group lowered their target price on Clorox from $139.00 to $125.00 and set a “buy” rating on the stock in a research note on Monday, May 4th. Wells Fargo & Company lowered their target price on Clorox from $100.00 to $95.00 and set an “equal weight” rating on the stock in a research note on Monday, May 18th. Weiss Ratings upgraded Clorox from a “sell (d+)” rating to a “hold (c-)” rating in a research note on Monday, April 13th. Finally, BNP Paribas Exane decreased their price target on Clorox from $128.00 to $97.00 and set a “neutral” rating for the company in a research note on Tuesday, May 12th. One investment analyst has rated the stock with a Buy rating, eleven have given a Hold rating and five have issued a Sell rating to the stock. Based on data from MarketBeat, the company has an average rating of “Reduce” and an average price target of $103.40.

Clorox Profile

The Clorox Company is a leading manufacturer and marketer of consumer and professional products designed to help people care for their homes and live healthy, sustainable lives. Its portfolio spans cleaning and household products, food and beverages, water filtration systems and cat litter, serving both retail and institutional customers. The company’s flagship bleach and disinfecting products are well known in the United States and many international markets, where they help prevent the spread of germs in homes, hospitals, schools and businesses.

Clorox’s diverse brand lineup includes liquid bleach and surface cleaners, eco-friendly cleaning tools, food preservation and preparation items, charcoal grills and briquettes, specialty foods and beverages, pet care products and personal care lines.